(Image: Seth Michael / Shutterstock.com)

This week, in an article published by online magazine CBD Today, The Rodman Law Group’s managing partner and founder, David Rodman, provided insight into the cannabidiol (“CBD“) industry and it’s current legal status.

Citing the Agriculture Improvement Act of 2018, Mr. Rodman explained the risks still associated with CBD businesses and products facing impending enforcement action from the U.S. Food and Drug Administration (“FDA“). He also noted the role of the FDA to ensure the safety of consumers now that the CBD industry is booming with products like Vitamin Shoppe’s consumable CBD soft gels pushing the existing regulatory boundaries.

For CBD Today‘s full article, click here.


The information in this blog post (the "Blog" or "Post") is provided as news and/or commentary for general informational purposes only. The information herein does not, and shall never, constitute legal advice and therefore cannot be relied upon as a legal opinion. Nothing in this Blog constitutes attorney communication and is not privileged information. Nothing in the Post or on this website creates any kind of attorney client relationship or privilege of any kind.